RD Technologies
Series A in 2024
RD Technologies Group (RD Technologies) is a financial platform that bridges the Web2 and Web3 worlds.
RD Technologies' secure and innovative solutions include:
• RD Wallet:
RD Wallet Technologies Limited (RD Wallet) is a licensed Stored Value Facility in Hong Kong (licence number: SVF0016). It enables global businesses to open multi-currency fiat accounts on mobile anytime, anywhere.
• HKDR Stablecoin (HKDR):
HKDR Stablecoin (HKDR) is a compliant and transparent Hong Kong Dollar stablecoin 1:1 backed by the Hong Kong dollar, with high-quality and highly liquid assets safekept in segregated custody accounts with licensed financial institutions. Details of the reserves will be available to the public through regular independent attestation reports. In July 2024, RD InnoTech Limited, the issuer of HKDR, was among the first batch of entities to be admitted to the stablecoin issuer sandbox by the Hong Kong Monetary Authority.
• HKDR Stablecoin (HKDR):
HKDR Stablecoin (HKDR) is a compliant and transparent Hong Kong Dollar stablecoin 1:1 backed by the Hong Kong dollar, with high-quality and highly liquid assets safekept in segregated custody accounts with licensed financial institutions. Details of the reserves will be available to the public through regular independent attestation reports. In July 2024, RD InnoTech Limited, the issuer of HKDR, was among the first batch of entities to be admitted to the stablecoin issuer sandbox by the Hong Kong Monetary Authority.
Xiaohongshu
Secondary Market in 2024
Xiaohongshu, founded in 2013 and based in Shanghai, China, is a lifestyle sharing platform that allows users to share experiences through text, images, and videos. Initially aimed at assisting overseas travelers with shopping, it has transformed into a vibrant community focused on various lifestyle areas, including cosmetics, fashion, food, travel, entertainment, reading, fitness, and childcare. The platform serves as a social e-commerce space where users can post their favorite products, share shopping experiences, and discover global merchandise, particularly in luxury and beauty sectors. By fostering user-generated content, Xiaohongshu encourages a collaborative environment for lifestyle enthusiasts to exchange insights and recommendations.
Xiaohongshu
Secondary Market in 2023
Xiaohongshu, founded in 2013 and based in Shanghai, China, is a lifestyle sharing platform that allows users to share experiences through text, images, and videos. Initially aimed at assisting overseas travelers with shopping, it has transformed into a vibrant community focused on various lifestyle areas, including cosmetics, fashion, food, travel, entertainment, reading, fitness, and childcare. The platform serves as a social e-commerce space where users can post their favorite products, share shopping experiences, and discover global merchandise, particularly in luxury and beauty sectors. By fostering user-generated content, Xiaohongshu encourages a collaborative environment for lifestyle enthusiasts to exchange insights and recommendations.
Micro Connect
Series C in 2023
Micro Connect is a market platform and infrastructure provider that links global capital with micro and small businesses in China. It develops fintech capabilities and platform infrastructure to enable liquidity in small business investing for professional investors. By offering direct exposure to the daily cash flows of millions of stores in China’s consumer economy through Daily Revenue Obligations, Micro Connect enables accessible and diversified investment opportunities while supporting business owners with affordable capital. The company also operates an ecosystem that includes a fund platform, structured product solutions, and a licensed exchange to support diverse investment approaches and transparent cash-flow investment options.
SUNRATE is a global payment and treasury management platform established in 2016, headquartered in Singapore with additional offices in Hong Kong, Jakarta, London, and Shanghai. The company provides a comprehensive solution for businesses to operate and scale internationally across over 190 countries and regions. SUNRATE's platform offers services such as international payments, virtual corporate cards, global collections, and treasury management, facilitating smooth commercial transactions and enhancing international trade. By leveraging its proprietary technology and extensive global network, SUNRATE partners with leading financial institutions like Citibank and Standard Chartered, and holds principal memberships with both Mastercard and Visa, positioning itself as a key player in the financial technology sector.
Shein
Venture Round in 2023
Founded in 2008, Shein is a global online marketplace specializing in women's fast fashion. It uses on-demand manufacturing technologies to connect suppliers with an agile supply chain, reducing inventory waste and offering affordable clothing, shoes, jewelry, and accessories to customers worldwide.
DeepLang AI
Venture Round in 2023
DeepLang AI is focused on developing a sophisticated information processing engine tailored for the Chinese market. Utilizing advanced artificial intelligence and natural language processing technologies, the company offers a range of capabilities including AI-generated content text generation, information extraction, aggregation, and semantic retrieval. This intelligent engine is designed to support workers and organizations in China, enhancing their productivity and efficiency in managing and analyzing textual data within information-intensive environments. By leveraging its self-developed large-scale model, DeepLang AI aims to provide robust solutions that address the unique challenges faced in processing and understanding large volumes of information.
Phabuilder
Series A in 2023
PhaBuilder is a technology-driven company established in February 2021 by Professor Guoqiang Chen, specializing in synthetic biology with a focus on the engineering application of halophilic microbes. The company employs advanced techniques in Next Generation Industrial Biotechnology to create high-value products such as biodegradable polyhydroxyalkanoates (PHA), ectoine, and cadaverine, targeting multiple sectors, including materials and pharmaceuticals. PhaBuilder is currently constructing two PHA production facilities in China and aims to establish 3-5 large-scale production sites within five years. The company utilizes an interdisciplinary approach that combines biology, engineering, and information technology to transform genetic programs, thereby offering sustainable solutions across diverse fields. With significant backing from notable investors, PhaBuilder is dedicated to integrating synthetic biotechnology into everyday life and advancing intelligent biological manufacturing, with the overarching goal of fostering a greener future through microbial innovation.
Locad enables e-commerce brands to expand omnichannel operations across Asia-Pacific by providing a logistics engine that automates storage, packing, shipping, and tracking of orders. Its cloud-based platform synchronizes inventory across online channels and facilitates end-to-end order fulfillment through a network of warehouses and carriers in Singapore, the Philippines, Thailand, Hong Kong, and Australia.
Haawking specializes in developing and manufacturing industrial control microprocessors and machine vision chips. Their products enhance computing efficiency and reduce costs for clients across industries such as industrial robots, augmented reality, autonomous driving, consumer electronics, and new energy automotive.
Zhonghai Chuneng Technology Beijing
Seed Round in 2022
Zhonghai Chuneng Technology Beijing develops energy storage technology and the production, and sales of energy storage equipment.
Cataya Bio
Series A in 2022
Cataya Bio (Shanghai) Co., Ltd. is a biotechnology company focused on developing synthetic biological products for various industries. Utilizing an advanced engineering biology platform, Cataya Bio engineers microbes and implements clean fermentation processes to produce high-purity products efficiently and sustainably. The company aims to facilitate the transition from petroleum-based materials to natural and sustainable raw materials, addressing critical global challenges such as environmental preservation, carbon emissions, and climate change. Through its innovative approach, Cataya Bio provides clients with effective solutions for sourcing raw materials that align with contemporary sustainability goals.
Insight Lifetech
Series D in 2022
Insight Lifetech is a medical technology company focused on developing and manufacturing innovative solutions for the diagnosis and treatment of cardiovascular diseases. The company has established a comprehensive platform that integrates research and development, manufacturing, and commercialization, facilitating collaboration across its operations. This synergy accelerates product development, enhances cost-efficiency, and fosters innovation. Notably, Insight Lifetech developed the first domestic fractional flow reserve (FFR) system in China, which received approval from the National Medical Products Administration. Through its high-quality medical devices and advanced technologies, the company aims to provide reliable precision in cardiovascular diagnosis and therapy, ultimately enabling physicians to save and improve patients' lives.
XellSmart
Series A in 2022
XellSmart is a company based in Minhang District, Shanghai, China, focused on developing stem cell treatment solutions for various degenerative diseases that currently lack effective clinical treatments. The firm aims to enhance disease treatment and facilitate drug discovery through innovative stem cell therapies. XellSmart is dedicated to offering large-scale and cost-effective stem cell treatment, replacement, and transplantation options, specifically targeting major conditions like Parkinson's disease. By advancing these solutions, XellSmart seeks to provide patients with viable clinical alternatives to improve their health outcomes.
Super Panther
Venture Round in 2022
Super Panther is a Chinese technology company focused on the new energy commercial vehicle market. It develops skateboard chassis technology and related systems to help customers build cost-effective energy replenishment ecosystems, including distributed electric drive axles, control algorithms, a high-voltage platform, an integrated thermal management system, and a chassis domain controller, with the goal of enabling smarter, more efficient logistics and zero-carbon operations.
HAI ROBOTICS
Series D in 2022
HAI ROBOTICS, founded in 2016 and based in Shenzhen, China, specializes in autonomous case-handling robotic systems for warehouse automation. The company offers a range of solutions, including intelligent goods-to-person and smart in-plant logistics systems, tailored for diverse operational scenarios. As a pioneer in this field, HAI ROBOTICS launched its first autonomous case-handling robot, HAIPICK, in 2015, which has since evolved through continuous research and development. The HAIPICK system enhances warehouse efficiency significantly, reportedly increasing operational efficiency by three to four times and storage density by 80% to 130%. HAI ROBOTICS holds multiple patents and serves a growing list of clients, providing flexible and customizable automation solutions to optimize warehousing operations and improve overall productivity.
Kaiyuan Communication Technology (Xiamen) Co., Ltd. is a specialized chip manufacturer based in Haicang District, Xiamen City. The company focuses on providing RF front-end solutions, developing advanced 4G+ and 5G RF filters and chips aimed at enhancing the domestic chip industry. With operational facilities in Zhangjiang, Shanghai, and sales and customer support centers in Shenzhen, Xi'an, and Beijing, Kaiyuan is positioned to serve the mobile device sector and the burgeoning Internet of Things (IoT) market. Its products are designed to deliver high-speed, high-quality connectivity, enabling users to experience faster and more stable connections in their devices.
Founded in 2008, Shein is a global online marketplace specializing in women's fast fashion. It uses on-demand manufacturing technologies to connect suppliers with an agile supply chain, reducing inventory waste and offering affordable clothing, shoes, jewelry, and accessories to customers worldwide.
Micro Connect
Series B in 2022
Micro Connect is a market platform and infrastructure provider that links global capital with micro and small businesses in China. It develops fintech capabilities and platform infrastructure to enable liquidity in small business investing for professional investors. By offering direct exposure to the daily cash flows of millions of stores in China’s consumer economy through Daily Revenue Obligations, Micro Connect enables accessible and diversified investment opportunities while supporting business owners with affordable capital. The company also operates an ecosystem that includes a fund platform, structured product solutions, and a licensed exchange to support diverse investment approaches and transparent cash-flow investment options.
XVERSE is a technology company platform that develops 3D user-generated content. It aims to become one of the operating systems (OS) of the true Internet and one of the important content providers.
The company is located in Shenzhen, China.
WeShine Network
Series B in 2022
WeShine Network is a marketing and service platform based in Nanjing, China, established in 2015. The company specializes in providing integrated marketing solutions, primarily utilizing the WeChat platform to facilitate corporate account management for business users. WeShine Network enables enterprises to attract and acquire customers through various channels, enhancing their marketing precision and broadening their customer base. With over 150,000 businesses served and more than 30,000 paid enterprise users, the company has built a substantial presence globally, supported by a network of over 600 channel partners. Its offices are located in major cities such as Guangzhou, Shenzhen, Beijing, Shanghai, Wuxi, and Wuhan.
Amber Group
Series B in 2022
Founded in Hong Kong in 2017 by finance professionals from Morgan Stanley and Goldman Sachs, Amber Group is a global crypto finance service provider. It offers liquidity provision, trading, and asset management services to over 200 institutional clients worldwide, facilitating trades worth $100-200 million daily across multiple exchanges.
Modalku is an online marketplace based in Jakarta, Indonesia, designed to connect small businesses seeking loans with lenders looking to fund these loans. By leveraging technology, Modalku offers borrowers access to financing options that may not be available through traditional channels, often at lower interest rates. Lenders participating in the platform can achieve returns that surpass those typically found in bank deposits and traditional investment products. This marketplace lending model has been successfully implemented in various countries, including the USA, UK, China, and Singapore, demonstrating its effectiveness in supporting small business growth.
Qianglian Zhichuang
Series C in 2022
the first high-tech company in China to focus on the treatment of cerebrovascular disease, it has more than four years of product research and development, leading China's cerebrovascular disease intelligence in an all-around way. vertical field of diagnosis and treatment. It has become a well-known brain stroke intelligence diagnosis and treatment platform in China.
Tongxin Medical Equipment
Series D in 2022
Tongxin makes magnetically-suspended artificial blood pumps which are designed to replace the human heart. They are undergoing clinical trials in China after being fast-tracked through the approval process by the National Medical Products Administration, state-run Xinhua News Agency
Phabuilder
Venture Round in 2022
PhaBuilder is a technology-driven company established in February 2021 by Professor Guoqiang Chen, specializing in synthetic biology with a focus on the engineering application of halophilic microbes. The company employs advanced techniques in Next Generation Industrial Biotechnology to create high-value products such as biodegradable polyhydroxyalkanoates (PHA), ectoine, and cadaverine, targeting multiple sectors, including materials and pharmaceuticals. PhaBuilder is currently constructing two PHA production facilities in China and aims to establish 3-5 large-scale production sites within five years. The company utilizes an interdisciplinary approach that combines biology, engineering, and information technology to transform genetic programs, thereby offering sustainable solutions across diverse fields. With significant backing from notable investors, PhaBuilder is dedicated to integrating synthetic biotechnology into everyday life and advancing intelligent biological manufacturing, with the overarching goal of fostering a greener future through microbial innovation.
Vibrant
Venture Round in 2022
Vibrant develops an AI drug development platform to focus on building immune system-related drug pipelines. The company will use artificial intelligence algorithms to accelerate the efficiency of drug development in various aspects such as target discovery, drug design, and drug efficacy evaluation; at the same time, the company expects to continuously improve the success rate of drug development through sustainable data accumulation and algorithm optimization.
It was founded and headed by Dr. Wang Luquan and is based in Guangzhou, Guangdong, China.
Virtue Diagnostics
Series B in 2022
Virtue Diagnostics (Suzhou) Co., Ltd. is an in vitro diagnostic (IVD) company based in Suzhou, China, with a research and development office in Singapore. Founded in 2019, the company specializes in developing advanced diagnostic platforms for the detection of infectious diseases, cancer, and chronic diseases. Its technology offerings include clinical mass spectrometry, multiplex immunohistochemistry for pathology-based cancer detection, and a molecular and immunoassay platform. Virtue Diagnostics aims to enhance diagnostic capabilities and improve patient outcomes through its innovative solutions.
Parametrix.ai
Series B in 2022
Parametrix.ai is a startup focused on revolutionizing game development through advanced artificial intelligence solutions. Founded in 2019 and headquartered in China, the company specializes in integrating AI capabilities into gaming scenarios, utilizing technologies such as machine learning and reinforcement learning. Parametrix.ai aims to create AI-driven virtual beings that coexist within a richly developed virtual world, enhancing the gaming experience by enabling complex environmental interactions, decision-making, and dynamic modeling of challenges such as team formation and player survival. By fostering collaboration between humans and AI, Parametrix.ai seeks to build an engaging, innovative, and inclusive gaming environment.
Treelab is a technology company founded in 2019 and based in Shanghai, China, that specializes in developing a productivity tool designed for non-technical users to create customized business systems without the need for programming skills. Its platform enables organizations to design and manage various business processes, including project management, customer relationship management, and human resource management. Treelab's software facilitates the creation of personalized solutions by allowing users to visualize records, compile data, and compare pricing, all while collaborating in real-time. By streamlining the sourcing process and connecting brands with accredited global factories, Treelab provides a user-friendly digital environment for managing products, suppliers, orders, and invoices efficiently.
Recurrent.ai
Venture Round in 2021
Recurrent.ai is a Chinese company that specializes in AI-enabled corporate services aimed at enhancing sales efficiency. The company utilizes advanced machine learning technologies to analyze sales calls and conversations, transforming voice interactions into text for comprehensive analysis. Its offerings include a self-study engine for sales dialogue, which allows businesses to generate detailed big data dialogue analysis reports and maintain customer portrait records. By automating these processes, Recurrent.ai helps organizations reduce time and labor costs, improve sales conversion rates, and enhance overall decision-making capabilities.
Foodism is a local e-commerce platform founded in 2020, specializing in providing online celebrity and lifestyle services. The company operates in 103 major cities across China, including Beijing, Shanghai, and Guangzhou, with plans to expand to 250 cities in the near future. Foodism collaborates with over 100,000 local businesses, primarily in the catering and entertainment sectors, and partners with more than 6,000 internet influencers to create engaging short video advertisements. The management team comprises experienced professionals from notable local life e-commerce companies, contributing to Foodism's strategic approach to local business management and advertising. With significant investment backing, Foodism aims to enhance its services and reach a wider audience for its clients.
Tungee, founded in 2016, specializes in providing intelligent sales solutions for B2B enterprises. By leveraging artificial intelligence and big data, the company has developed a comprehensive sales forecasting platform that encompasses various functions, including lead mining, business opportunity engagement, customer relationship management, and order analysis. Tungee's innovative approach addresses the challenges faced by businesses in identifying, contacting, and managing customers, leading to more efficient acquisition of accurate sales leads and reduced customer acquisition costs. As a leader in the Chinese intelligent sales sector, Tungee has successfully served over 3,000 enterprise clients, including prominent organizations such as Alibaba and China Mobile.
Len Technology
Series B in 2021
Len Technology Ltd. is a Chinese manufacturer of automotive‑grade analog integrated circuits, including DC/DC switching regulators and linear regulators. Its products support automotive positioning, assisted driving, battery management, motor drive, air‑conditioning systems, industrial automation, electric‑bike power modules, and consumer electronics. Founded in 2017, the company is headquartered in Wuxi, China.
J&T Express
Private Equity Round in 2021
Founded in 2015, J&T Express is a leading logistics service provider specializing in express delivery and courier services. It operates across 13 countries, with dominant market positions in Southeast Asia and China, and expanding footprints in Latin America and the Middle East.
ComGen Biopharmaceutical
Series A in 2021
ComGen Pharma is a biotechnology company that specializes in the research and development of innovative therapeutic drugs targeting the complement system. The company aims to create effective immunotherapies for autoimmune diseases and tumors by focusing on new and key targets within this biological pathway. Recently, ComGen Pharma secured nearly 100 million yuan in financing, which will primarily support phase I clinical trials for its complement inhibitors, advance its drug pipeline, and enhance its innovative drug research and development platform. The financing round was led by prominent investors, including Sequoia China and Yahui Investment, with additional support from Fuchuang Investment and Renyou Investment.
ThinkingData
Series C in 2021
ThinkingData operates a big data analysis platform specifically designed for the gaming industry. The company utilizes advanced natural language processing and text mining technologies to provide users with real-time insights into player behavior, feedback, and public opinion on products. This comprehensive analysis aids gaming businesses in optimizing product experiences, enhancing operational efficiency, and driving user engagement and revenue growth. By offering a self-service data acquisition system, ThinkingData improves data awareness and analysis capabilities for its clients, enabling them to achieve greater data efficiency while reducing analytical costs.
Cellular Biomedicine Group
Series A in 2021
Cellular Biomedicine Group, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative immunotherapies for cancer and stem cell therapies for degenerative diseases in Greater China. The company employs proprietary cell-based technologies, including various forms of CAR-T therapy, which targets different cancer types, and human adipose-derived mesenchymal progenitor cells aimed at treating joint diseases. Its product pipeline features therapies such as CD20 and CD22 CAR-T for B cell malignancies, and alpha fetoprotein TCR-T targeting hepatocellular carcinoma. Additionally, Cellular Biomedicine is developing knee osteoarthritis treatments, including AlloJoin and Re-Join, the latter having completed Phase IIb trials. The company also engages in broader biopharmaceutical activities, encompassing research and development, technical support, and manufacturing of pharmaceutical polypeptides and medical devices. It has established a partnership with Novartis Pharma AG to produce and supply the CAR-T cell therapy Kymriah in China. Founded in 2001, Cellular Biomedicine Group is headquartered in New York, New York, and draws on a wealth of cellular medicine research and expertise from scientists and clinicians across the United States, England, and China.
Founded in 2017, Xreal is a pioneering developer of ready-to-wear mixed reality glasses. Its flagship product, Nreal Light, offers lightweight comfort and vivid display, enhanced by spatial computing algorithms for an immersive user experience. The company's mission is to make mixed reality accessible to all, empowering developers to create innovative applications across entertainment and productivity.
HAI ROBOTICS
Series D in 2021
HAI ROBOTICS, founded in 2016 and based in Shenzhen, China, specializes in autonomous case-handling robotic systems for warehouse automation. The company offers a range of solutions, including intelligent goods-to-person and smart in-plant logistics systems, tailored for diverse operational scenarios. As a pioneer in this field, HAI ROBOTICS launched its first autonomous case-handling robot, HAIPICK, in 2015, which has since evolved through continuous research and development. The HAIPICK system enhances warehouse efficiency significantly, reportedly increasing operational efficiency by three to four times and storage density by 80% to 130%. HAI ROBOTICS holds multiple patents and serves a growing list of clients, providing flexible and customizable automation solutions to optimize warehousing operations and improve overall productivity.
HAI ROBOTICS
Series C in 2021
HAI ROBOTICS, founded in 2016 and based in Shenzhen, China, specializes in autonomous case-handling robotic systems for warehouse automation. The company offers a range of solutions, including intelligent goods-to-person and smart in-plant logistics systems, tailored for diverse operational scenarios. As a pioneer in this field, HAI ROBOTICS launched its first autonomous case-handling robot, HAIPICK, in 2015, which has since evolved through continuous research and development. The HAIPICK system enhances warehouse efficiency significantly, reportedly increasing operational efficiency by three to four times and storage density by 80% to 130%. HAI ROBOTICS holds multiple patents and serves a growing list of clients, providing flexible and customizable automation solutions to optimize warehousing operations and improve overall productivity.
Syrius Robotics
Series B in 2021
Syrius Robotics is a manufacturer of intelligent robots designed for material handling, particularly within factories and logistics environments. Founded in 2018 and headquartered in Shenzhen, China, with an additional office in Beijing, the company specializes in autonomous mobile robots that utilize a self-developed operational system and software platform, supported by AIoT cloud services. Syrius Robotics partners with fulfillment centers and warehouses globally, offering versatile automation solutions tailored for e-commerce, retail, and logistics sectors. Its innovative logistics robots, which incorporate advanced technologies such as laser radar and cameras, aim to enhance productivity in automated logistics and warehouse operations. The company's solutions are increasingly being adopted by various commercial organizations beyond the transportation industry, demonstrating its broad applicability and impact on efficiency in different sectors.
XtalPi is a pharmaceutical technology company that applies quantum mechanics, artificial intelligence, and high-performance computing to accelerate drug discovery and development. Its Intelligent Digital Drug Discovery and Development platform weaves physics-based modeling with AI to increase efficiency, accuracy, and success rates at critical stages of R&D. The company offers tools for crystal structure prediction and determination, solid-state testing and analysis, and crystallization process development, as well as solid-state screening and evaluation, enabling faster optimization of drug candidates. XtalPi also provides drug design support for small molecules and collaboration options in antibody and peptide research, and offers platform-based AI model development and integration across pharmaceutical workflows. Founded in 2014, it is based in Cambridge, Massachusetts, with additional offices in China.
Harvest Capital Management
Funding Round in 2021
Harvest Capital Management Co., Ltd. is a fund management company based in China and operates as a subsidiary of Harvest Fund Management Co. Ltd. Established in 2012, it is approved by the China Securities Regulatory Commission and specializes in client asset management services. The firm leverages the expertise, talent, and risk control capabilities of its parent company to offer tailored asset management solutions. Harvest Capital Management aims to provide a broader and more flexible range of investment options within the securities management sector. The company is also linked to Harvest Real Estate Investments, a joint venture focused on private equity real estate, emphasizing its diverse investment strategies.
Miaoshou Doctor
Series F in 2021
Miaoshou Doctor is a healthcare service platform established in 2015 by Tao He and Daoliang Han, headquartered in Beijing. The company focuses on facilitating communication between patients and healthcare professionals, enabling effective management of post-diagnosis outcomes. Its platform empowers doctors to actively monitor their patients' health through ongoing counseling and prescription support, enhancing the overall patient care experience. By streamlining interactions and follow-ups, Miaoshou Doctor aims to improve health outcomes and foster better relationships between patients and their healthcare providers.
Anovent Pharmaceutical
Venture Round in 2021
Shanghai Anovent Pharmaceutical Co., Ltd., founded in 2017 and headquartered in Shanghai, China, specializes in the development of high-quality inhalation medicines tailored for hospitals and medical institutions. The company focuses on offering safe and affordable pharmaceutical products, which include both generic and specialized inhalation therapies. By providing these medications, Anovent aims to enhance the quality of medical treatment available to patients in healthcare settings.
Bota Biosciences
Series B in 2021
Bota Biosciences is a global industrial biotechnology company based in Hangzhou, China, founded in 2019. The company specializes in synthetic bioengineering technology for bio-manufacturing, focusing on developing efficient, eco-friendly, and cost-effective biomanufacturing processes. Bota has created an integrative bioengineering platform that connects biological design with scale-up manufacturing, facilitating the production of high-performing industrial compounds through advanced fermentation processes. To support its innovative solutions, Bota has established a pilot plant and manufacturing facility, which enables the company to deliver scalable industrial solutions and market-ready products. Its infrastructure is designed to assist customers and partners across various industries, including nutrition, food, personal care, and animal health. Bota Biosciences is committed to accelerating shifts toward sustainable living by leveraging its multidisciplinary team's expertise to drive impactful biotech innovations.
Phabuilder
Angel Round in 2021
PhaBuilder is a technology-driven company established in February 2021 by Professor Guoqiang Chen, specializing in synthetic biology with a focus on the engineering application of halophilic microbes. The company employs advanced techniques in Next Generation Industrial Biotechnology to create high-value products such as biodegradable polyhydroxyalkanoates (PHA), ectoine, and cadaverine, targeting multiple sectors, including materials and pharmaceuticals. PhaBuilder is currently constructing two PHA production facilities in China and aims to establish 3-5 large-scale production sites within five years. The company utilizes an interdisciplinary approach that combines biology, engineering, and information technology to transform genetic programs, thereby offering sustainable solutions across diverse fields. With significant backing from notable investors, PhaBuilder is dedicated to integrating synthetic biotechnology into everyday life and advancing intelligent biological manufacturing, with the overarching goal of fostering a greener future through microbial innovation.
Cloudwise
Series E in 2021
Founded in 2009, Cloudwise is a prominent provider of full-stack Artificial Intelligence for IT Operations (AIOps) solutions in China. The company focuses on optimizing IT operations, electric power IT operations, and Internet of Things (IoT) operations through its comprehensive platform, which encompasses IT Operations Management (ITOM), IT Operations Analytics (ITOA), IT Service Management (ITSM), DevOps, and IoT. Cloudwise has invested significantly in independent research and development, resulting in a robust industrial landscape. Headquartered in Beijing, the company operates three R&D centers in Beijing, Yanjiao, and Zhengzhou, along with three operational centers in Shanghai, Guangzhou, and Chengdu. Additionally, it has branches in Hong Kong, Singapore, Thailand, and Malaysia, providing extensive marketing services and technical support throughout China and Southeast Asia, thereby enhancing business operations and decision-making for its clients.
HeyTea is a Chinese tea shop that focuses on innovative beverages, particularly cheese-topped tea and fruit tea. Founded in 2012 in an alley by the riverside, the company initially operated under the name ROYALTEA before rebranding to HEYTEA. The franchise offers a diverse range of products, including instant milk tea, fruit tea, and traditional Chinese tea, aimed at providing customers with unique flavor combinations. Through its distinct offerings, HeyTea has established itself as a prominent player in the tea beverage market.
dMed Company Limited, also known as dMed Biopharmaceutical Co., Ltd., is a clinical contract research organization based in Shanghai, China. Established in 2016, dMed specializes in offering a comprehensive range of services to support the development of medicines and medical devices. Its offerings include consulting, clinical operations, biostatistics and programming, data management, pharmacovigilance, clinical science and medical affairs, quality assurance, and regulatory affairs and strategy. The company serves a diverse clientele, including biopharmaceutical and medical device companies, and aims to establish itself as a prominent international brand in the field of drug innovation services and solutions.
neoX Biotech
Venture Round in 2021
neoX Biotech is a Beijing-based biotechnology company founded in 2018 that specializes in the development of antigen-based cancer vaccines. By integrating artificial intelligence with biophysics, neoX Biotech focuses on the discovery and development of macromolecular and multispecific drugs, primarily in the field of immuno-oncology. The company has established a platform for early therapeutic discovery, which includes neoantigen prediction and T cell receptor screening, as well as the characterization of protein-protein interactions. This innovative approach aims to provide effective treatments for cancer patients by advancing drug research and development.
Chehaoduo
Series E in 2021
Chehaoduo designs an online car trading platform that sells used cars. Its online car trading platform directly links individual car sellers and buyers, which help buyers remove the middlemen as well as purchase used cars easily.
Haoyong Yang founded Chehaoduo in 2014, with its headquarters in Beijing in China, with branches in Chinese cities such as Hangzhou and Chongqing.
Qingteng Cloud Security
Series C in 2021
Qingteng Cloud Security is a Beijing-based company that specializes in cloud security solutions, particularly focusing on endpoint adaptive security. Founded in 2014, it offers a comprehensive suite of security software that integrates prediction, prevention, detection, and response capabilities. The company's products are built on Adaptive Security Architecture, enabling organizations to enhance their security postures across various industries. Qingteng's asset inventory data platform is capable of identifying over 800 types of business applications and managing key assets across multiple mainframes. This platform supports the development of information security systems that comply with domestic laws and regulations, catering to government and enterprise needs. Additionally, Qingteng provides next-generation host security technology, ensuring robust protection for critical endpoints.
Micro Connect
Series A in 2021
Micro Connect is a market platform and infrastructure provider that links global capital with micro and small businesses in China. It develops fintech capabilities and platform infrastructure to enable liquidity in small business investing for professional investors. By offering direct exposure to the daily cash flows of millions of stores in China’s consumer economy through Daily Revenue Obligations, Micro Connect enables accessible and diversified investment opportunities while supporting business owners with affordable capital. The company also operates an ecosystem that includes a fund platform, structured product solutions, and a licensed exchange to support diverse investment approaches and transparent cash-flow investment options.
Beijing Beisen Cloud Computing Co., Ltd. specializes in developing software as a service (SaaS) solutions for integrated talent management. Founded in 2005 and based in Beijing, the company offers a comprehensive platform that includes services for talent assessment, recruitment management, performance management, succession planning, and employee development. Beisen’s Human Resource Service Platform focuses on internet recruitment, while its Business People Service Network provides information and recruitment services. The company also delivers platform as a service (PaaS) for cloud architecture development, along with system implementation and custom development services. Its iTalentX platform features cloud-native applications designed to streamline human capital management (HCM) processes, enabling organizations to effectively recruit, evaluate, and retain talent throughout the employee lifecycle.
EdiGene Inc. is a biotechnology company specializing in the development of genome editing technologies for therapeutic applications in cancer and various genetic diseases. Founded in 2015 and headquartered in Beijing, China, with additional offices in Guangzhou and Cambridge, Massachusetts, EdiGene focuses on both ex vivo and in vivo gene-editing therapies. The company has established proprietary platforms for editing hematopoietic stem cells and T cells, as well as an RNA base editing approach for in vivo applications. EdiGene's innovative methods enable targeted modifications of genetic information in human cells and facilitate high-throughput drug discovery through advanced screening techniques. By translating these technologies into novel therapeutics, EdiGene aims to improve the safety and efficacy of gene therapy, ultimately benefiting patients, the pharmaceutical industry, and the scientific research community.
Connect Medical Value Technology
Series A in 2021
Connect Medical Value Technology is a company established in 2020 and based in Hangzhou, Zhejiang, China. It specializes in developing mobile applications designed for physicians, offering a comprehensive platform that integrates clinical services, scientific research, and educational resources. The company's applications leverage advanced artificial intelligence technology to enhance medical practice and improve healthcare delivery. Through its innovative solutions, Connect Medical Value aims to support healthcare professionals in their clinical decision-making and ongoing education.
J&T Express
Private Equity Round in 2021
Founded in 2015, J&T Express is a leading logistics service provider specializing in express delivery and courier services. It operates across 13 countries, with dominant market positions in Southeast Asia and China, and expanding footprints in Latin America and the Middle East.
Qihan Biotech
Series A in 2021
Qihan Biotech is a biomedical company specializing in genetic technology with a focus on addressing the global shortage of organ donors. The company aims to produce safe and effective cells, tissues, and organs for human transplantation using advanced gene editing techniques. By applying these technologies to xenogenic organ transplantation, Qihan Biotech seeks to create organs that can be transplanted into humans, thereby reducing the need for traditional organ transplants and saving lives.
Neuracle is a prominent enterprise in China's neuroscience sector, specializing in neural monitoring and diagnostic technology. Leveraging advanced brain-machine interface technology developed through collaboration with Tsinghua University, Neuracle focuses on innovative research in neuroscience, psychology, and neuroengineering. The company provides comprehensive solutions for the diagnosis, treatment, and rehabilitation of clinical neurological diseases. Its product offerings include digital electroencephalographs and other tools that allow healthcare institutions to monitor patients' brain bioelectricity levels and accurately diagnose neural conditions. Neuracle's research and development efforts have garnered acceptance from experts in both neuroscience and clinical medicine, positioning the company as a leader in its field and a key contributor to national science and technology initiatives.
Muxi is dedicated to providing full-stack GPU chips and heterogeneous computing solutions that can be widely used in cutting-edge fields such as artificial intelligence, smart cities, data centers, cloud computing, autonomous driving, digital twins, metaverse, and so on. It builds full-stack GPU chip products, launching MXN series GPUs (Xi Si) for AI reasoning, MXC series GPUs (Xi Yun) for AI training and general computing, and MXG series GPUs (Xi Cai) for graphics rendering, Meet the computing power requirements of data centers for "high energy efficiency" and "high versatility". Mu Xi's products all use independently developed GPU IP, have instruction sets and architectures with completely independent intellectual property rights, and are outfitted with a complete software stack (MACAMACA) compatible with mainstream GPU ecosystems.
In September 2020, the company was founded in Shanghai, and it has wholly-owned subsidiaries and R&D centers in Beijing, Nanjing, Chengdu, Hangzhou, Shenzhen, and Wuhan.
Tim Hortons China
Venture Round in 2021
Tim Hortons China is a subsidiary of Tim Hortons Inc., established in 2018 and headquartered in Shanghai. The company operates a chain of coffee restaurants that serve a variety of coffee products alongside food offerings, including made-to-order shrimp sandwiches and salads. Tim Hortons China emphasizes customer service, addressing inquiries through multiple channels such as phone, email, and online applications. The company aims to provide a unique dining experience by blending coffee culture with fresh meal options in the Chinese market.
Moore Threads
Seed Round in 2021
Founded in 2020, Moore Threads specializes in developing Graphics Processing Unit technology for corporate clients across sectors such as gaming, creative industries, and artificial intelligence. Its GPU solutions cater to data centers, edge computing servers, professional workstations, and high-performance PCs.
Furong Xingsheng
Venture Round in 2021
Furong Xingsheng is a Chinese company based in Changsha that owns and operates convenience stores. Established in 2009, it specializes in providing B2B logistics and distribution services. The company also functions through its community shopping platform, Xingsheng Youxuan, launched in 2018, which caters to consumers by offering fresh produce, meat, seafood, staples, and general merchandise. This platform employs a unique retail model that combines online ordering with offline pick-up, allowing household consumers to meet their daily needs conveniently through a network of community-based convenience stores.
neoX Biotech
Series A in 2021
neoX Biotech is a Beijing-based biotechnology company founded in 2018 that specializes in the development of antigen-based cancer vaccines. By integrating artificial intelligence with biophysics, neoX Biotech focuses on the discovery and development of macromolecular and multispecific drugs, primarily in the field of immuno-oncology. The company has established a platform for early therapeutic discovery, which includes neoantigen prediction and T cell receptor screening, as well as the characterization of protein-protein interactions. This innovative approach aims to provide effective treatments for cancer patients by advancing drug research and development.
WeShine Network
Series A in 2021
WeShine Network is a marketing and service platform based in Nanjing, China, established in 2015. The company specializes in providing integrated marketing solutions, primarily utilizing the WeChat platform to facilitate corporate account management for business users. WeShine Network enables enterprises to attract and acquire customers through various channels, enhancing their marketing precision and broadening their customer base. With over 150,000 businesses served and more than 30,000 paid enterprise users, the company has built a substantial presence globally, supported by a network of over 600 channel partners. Its offices are located in major cities such as Guangzhou, Shenzhen, Beijing, Shanghai, Wuxi, and Wuhan.
Xiaobangguihua
Series B in 2021
Xiaobangguihua is an intelligent investment advisory service platform tailored for Chinese middle-class families. The company offers financial management and risk education through personalized consultation plans, enabling clients to make informed investment decisions. Leveraging advanced artificial intelligence algorithms and sophisticated asset allocation models, Xiaobangguihua provides systematic financial solutions aimed at optimizing investment outcomes. Its services include various tools and applications designed to assist users in managing their finances effectively. The company’s mission is to empower individuals to improve their financial literacy and utilize their resources more wisely.
4Paradigm
Series D in 2021
4Paradigm is a leading artificial intelligence technology company that empowers enterprises to improve efficiency, reduce risks, and derive greater value from data through accurate prediction and mining. It specializes in migration learning, considered the next generation of AI technology.
Rongyisuan
Series B in 2021
Rongyisuan, a Chinese startup that provides customized tax and accounting solutions for corporate customers.
.
Lalamove, originally launched as EasyVan in December 2013 in Hong Kong, is an on-demand logistics platform that connects customers with driver-partners for rapid delivery services. Operating in 21 markets across Asia and Latin America, the company serves over 7 million customers and boasts a network of more than 700,000 drivers. Lalamove has transformed traditional van hiring by enabling instant matches between customers and drivers, often within 12 seconds. The platform facilitates same-day deliveries, typically completing local deliveries within 55 minutes. Additionally, Lalamove provides features such as real-time vehicle tracking and driver ratings, allowing businesses to efficiently scale their delivery operations while optimizing drivers’ routes and earnings.
Visen Pharmaceuticals
Series B in 2021
Visen Pharmaceuticals is an innovative biopharmaceutical company focused on developing and providing advanced treatments for endocrine diseases in China. With a patient-centric approach, Visen aims to deliver first-in-class or best-in-class products, covering both common and rare endocrine conditions in adults and children. The company leverages cutting-edge technologies and global resources, with established offices in Shanghai, Beijing, Hong Kong, and Taipei, along with a Greater China R&D and manufacturing site in Suzhou.
Hive Box Technology
Series C in 2021
Founded in 2015 and based in Shenzhen, China, Hive Box Technology operates a network of self-service package drop-off and pick-up stations primarily aimed at enhancing the logistics of express delivery and e-commerce. The company has developed a 24-hour self-service platform that allows customers to conveniently store and retrieve packages at their leisure, thereby improving the efficiency of package handling in residential areas. By focusing on accessibility and user experience, Hive Box facilitates seamless interactions between consumers and logistics services, positioning itself as a key player in the evolving landscape of package delivery in China.
Insight Lifetech
Series C in 2020
Insight Lifetech is a medical technology company focused on developing and manufacturing innovative solutions for the diagnosis and treatment of cardiovascular diseases. The company has established a comprehensive platform that integrates research and development, manufacturing, and commercialization, facilitating collaboration across its operations. This synergy accelerates product development, enhances cost-efficiency, and fosters innovation. Notably, Insight Lifetech developed the first domestic fractional flow reserve (FFR) system in China, which received approval from the National Medical Products Administration. Through its high-quality medical devices and advanced technologies, the company aims to provide reliable precision in cardiovascular diagnosis and therapy, ultimately enabling physicians to save and improve patients' lives.
Lalamove, originally launched as EasyVan in December 2013 in Hong Kong, is an on-demand logistics platform that connects customers with driver-partners for rapid delivery services. Operating in 21 markets across Asia and Latin America, the company serves over 7 million customers and boasts a network of more than 700,000 drivers. Lalamove has transformed traditional van hiring by enabling instant matches between customers and drivers, often within 12 seconds. The platform facilitates same-day deliveries, typically completing local deliveries within 55 minutes. Additionally, Lalamove provides features such as real-time vehicle tracking and driver ratings, allowing businesses to efficiently scale their delivery operations while optimizing drivers’ routes and earnings.
Huolala offers logistics services, moving, less-than-truckload, car rental and sales, and after-car services.
Founded in 2013 and grown in the Guangdong-Hong Kong-Macao Greater Bay Area.
dMed Company Limited, also known as dMed Biopharmaceutical Co., Ltd., is a clinical contract research organization based in Shanghai, China. Established in 2016, dMed specializes in offering a comprehensive range of services to support the development of medicines and medical devices. Its offerings include consulting, clinical operations, biostatistics and programming, data management, pharmacovigilance, clinical science and medical affairs, quality assurance, and regulatory affairs and strategy. The company serves a diverse clientele, including biopharmaceutical and medical device companies, and aims to establish itself as a prominent international brand in the field of drug innovation services and solutions.
Founded in 2015 as a spinoff from Aviation Industry Corporation of China (AVIC), CALB is a leading new energy company headquartered in Changzhou, Jiangsu Province. It specializes in the development, production, sales, and market application of lithium-ion batteries, battery management systems, related integrated products, and lithium battery materials. Its primary product offerings include electric vehicle batteries and energy storage system products.
CassTime is an industrial internet company based in China that focuses on the automotive aftermarket. The company operates a comprehensive trading platform that offers full coverage of spare parts, facilitating transactions between buyers and sellers. In addition to its marketplace, CassTime provides a software-as-a-service (SaaS) management system tailored for automotive workshops, enhancing operational efficiency. The company also engages in supply chain finance and offers logistics services, ensuring streamlined processes for its users. By delivering detailed information on vehicle parts and supporting simpler settlements and aftersales services, CassTime enables a complete business-to-business transaction experience in the auto parts sector.
Moore Threads
Seed Round in 2020
Founded in 2020, Moore Threads specializes in developing Graphics Processing Unit technology for corporate clients across sectors such as gaming, creative industries, and artificial intelligence. Its GPU solutions cater to data centers, edge computing servers, professional workstations, and high-performance PCs.
Jiangxing Intelligence
Series A in 2020
Jiangxing Intelligence Inc., founded in 2018 and headquartered in Beijing, China, specializes in the development and operation of artificial intelligence-driven cloud-side collaborative Internet of Things (IoT) devices. The company provides innovative solutions such as EdgeBox, which facilitates real-time processing of big data and AI for industrial sectors, including manufacturing, oil and gas, hydropower, transportation, mining, renewable energy, and smart cities. Additionally, Jiangxing Intelligence offers the Ubiquitous Wisdom Eye, an intelligent monitoring device designed for transmission lines that integrates data from various sensors to create a comprehensive supervision platform. Founded by Professor Liu Jiangchuan, a recognized academician and IEEE Fellow, the company is dedicated to advancing edge computing technology and its applications in energy, industrial security, and intelligent warehousing. With additional offices in Shenzhen and Nanjing, Jiangxing Intelligence aims to enhance operational efficiency and safety in large-scale systems across multiple industries.
Cloudwise
Series D in 2020
Founded in 2009, Cloudwise is a prominent provider of full-stack Artificial Intelligence for IT Operations (AIOps) solutions in China. The company focuses on optimizing IT operations, electric power IT operations, and Internet of Things (IoT) operations through its comprehensive platform, which encompasses IT Operations Management (ITOM), IT Operations Analytics (ITOA), IT Service Management (ITSM), DevOps, and IoT. Cloudwise has invested significantly in independent research and development, resulting in a robust industrial landscape. Headquartered in Beijing, the company operates three R&D centers in Beijing, Yanjiao, and Zhengzhou, along with three operational centers in Shanghai, Guangzhou, and Chengdu. Additionally, it has branches in Hong Kong, Singapore, Thailand, and Malaysia, providing extensive marketing services and technical support throughout China and Southeast Asia, thereby enhancing business operations and decision-making for its clients.
D3 Bio, established in 2020, is a biotechnology company headquartered in China. It specializes in the development and registration of innovative medicines, primarily focusing on oncology and immunology. The company's approach involves analyzing clinical and market data to identify gaps in current treatments, employing unique drug development methodologies to target new disease areas and routes, and ultimately providing patients with alternative therapeutic options.
Zhiketong Technology
Series D in 2020
Beijing Zhiketong Technology Co., Ltd., established in 2014, specializes in providing direct marketing services for the hospitality, leisure, and entertainment sectors through its web platform on WeChat. The company acts as an agency that offers a range of digital marketing solutions, including consulting, advertising, and comprehensive data analysis. By assisting partners in optimizing their management efficiency and enhancing service quality, Zhiketong Technology helps businesses increase brand awareness and attract more customers. Its services encompass intelligent data analysis systems, online marketing strategies, customer management tools, and online store design, all aimed at driving revenue growth for hotels and tourism attractions in China.
Jizhibao is a Beijing-based company founded in 2009 that specializes in developing a cloud platform for engineering project management. The company offers a comprehensive suite of services tailored for the engineering construction industry, including metering and payment solutions for various sectors such as highways, subways, municipal administration, housing construction, hydropower, water conservancy, ports, shipping, and railways. Additionally, Jizhibao's platform facilitates project supervision, quality and safety inspections, contract management, engineering logs, and attendance maintenance, making it a versatile tool for managing complex engineering projects.
VanTop Group
Series A in 2020
VanTop Group is an Internet technology company headquartered in Shenzhen, with subsidiaries in the United States, Hong Kong, Europe, and Japan. The company focuses on independent research and development, emphasizing product innovation in the consumer electronics sector. VanTop specializes in the development and retail of smart electronic devices, including projectors, tablets, drones, and smart home products. With a mission to "Explore the Beauty of Life," VanTop aims to establish itself as a leading global consumer brand by leveraging globalization, branding operations, technological advancements, and localized strategies to deliver high-quality products to consumers worldwide.
SmartSens Technology
Series B in 2020
SmartSens Technology is a company based in Shanghai that specializes in the research, development, design, and sales of high-performance CMOS image sensor chips. The company offers advanced imaging solutions applicable in various sectors, including surveillance, machine vision, automotive, and mobile cameras. With a commitment to innovation, SmartSens aims to enhance growth across multiple industries by providing a diverse and comprehensive portfolio of image sensors.
EdiGene Inc. is a biotechnology company specializing in the development of genome editing technologies for therapeutic applications in cancer and various genetic diseases. Founded in 2015 and headquartered in Beijing, China, with additional offices in Guangzhou and Cambridge, Massachusetts, EdiGene focuses on both ex vivo and in vivo gene-editing therapies. The company has established proprietary platforms for editing hematopoietic stem cells and T cells, as well as an RNA base editing approach for in vivo applications. EdiGene's innovative methods enable targeted modifications of genetic information in human cells and facilitate high-throughput drug discovery through advanced screening techniques. By translating these technologies into novel therapeutics, EdiGene aims to improve the safety and efficacy of gene therapy, ultimately benefiting patients, the pharmaceutical industry, and the scientific research community.
XtalPi is a pharmaceutical technology company that applies quantum mechanics, artificial intelligence, and high-performance computing to accelerate drug discovery and development. Its Intelligent Digital Drug Discovery and Development platform weaves physics-based modeling with AI to increase efficiency, accuracy, and success rates at critical stages of R&D. The company offers tools for crystal structure prediction and determination, solid-state testing and analysis, and crystallization process development, as well as solid-state screening and evaluation, enabling faster optimization of drug candidates. XtalPi also provides drug design support for small molecules and collaboration options in antibody and peptide research, and offers platform-based AI model development and integration across pharmaceutical workflows. Founded in 2014, it is based in Cambridge, Massachusetts, with additional offices in China.
Recurrent.ai
Series B in 2020
Recurrent.ai is a Chinese company that specializes in AI-enabled corporate services aimed at enhancing sales efficiency. The company utilizes advanced machine learning technologies to analyze sales calls and conversations, transforming voice interactions into text for comprehensive analysis. Its offerings include a self-study engine for sales dialogue, which allows businesses to generate detailed big data dialogue analysis reports and maintain customer portrait records. By automating these processes, Recurrent.ai helps organizations reduce time and labor costs, improve sales conversion rates, and enhance overall decision-making capabilities.
Founded in 2017, Xreal is a pioneering developer of ready-to-wear mixed reality glasses. Its flagship product, Nreal Light, offers lightweight comfort and vivid display, enhanced by spatial computing algorithms for an immersive user experience. The company's mission is to make mixed reality accessible to all, empowering developers to create innovative applications across entertainment and productivity.
Saturnbird Coffee
Series B in 2020
Saturnbird Coffee Co., Ltd is a coffee shop operator based in Changsha, China, established in 2011. The company specializes in a range of coffee products, including a unique instant coffee powder that utilizes advanced brewing technology to preserve the original flavor and aroma of coffee beans. This innovative product can be dissolved in various liquids, such as hot or cold water, milk, and oat milk, allowing for versatile consumption. Saturnbird Coffee aims to enhance the coffee drinking experience through its thoughtfully designed cafes, which focus on the choice of utensils and interior aesthetics, creating an inviting atmosphere for coffee enthusiasts.
iSpace China
Series B in 2020
iSpace China, founded in 2016 and headquartered in Beijing, specializes in the development of commercial launch vehicles and space shuttles for aerospace customers globally. The company focuses on providing innovative solutions for the burgeoning commercial space industry, aiming to meet the increasing demand for satellite deployment and other aerospace services. By leveraging advanced technology and engineering expertise, iSpace China positions itself as a key player in the competitive landscape of commercial aerospace.
Dizal Pharma
Venture Round in 2020
Dizal Pharmaceutical is a research-driven biotechnology company that specializes in the discovery, development, and commercialization of innovative medicines. The company focuses on creating first-in-class and best-in-class therapeutic solutions, emphasizing the development of groundbreaking drugs. With a commitment to advancing healthcare, Dizal engages in extensive research and development activities, alongside production and sales of its pharmaceutical products. Through its efforts, Dizal aims to contribute significantly to the pharmaceutical industry by delivering effective treatments that address unmet medical needs.
LP Pharmaceuticals
Series C in 2020
LP Pharmaceuticals (Xiamen) Co., Ltd., located in Xiamen Biomedical Industry Base which formulates and manufactures pharmaceuticals with enhanced delivery properties. The company was founded in 2012 by a group of scientists and business professionals with extensive experience in the US and Chinese pharmaceutical industry. Proprietary delivery platforms include mucosal and oral controlled release. Therapeutic areas currently concern central nervous system, digestive system, cardiovascular, cancer and AIDS.
WeShine Network
Series A in 2020
WeShine Network is a marketing and service platform based in Nanjing, China, established in 2015. The company specializes in providing integrated marketing solutions, primarily utilizing the WeChat platform to facilitate corporate account management for business users. WeShine Network enables enterprises to attract and acquire customers through various channels, enhancing their marketing precision and broadening their customer base. With over 150,000 businesses served and more than 30,000 paid enterprise users, the company has built a substantial presence globally, supported by a network of over 600 channel partners. Its offices are located in major cities such as Guangzhou, Shenzhen, Beijing, Shanghai, Wuxi, and Wuhan.
Furong Xingsheng
Series C in 2020
Furong Xingsheng is a Chinese company based in Changsha that owns and operates convenience stores. Established in 2009, it specializes in providing B2B logistics and distribution services. The company also functions through its community shopping platform, Xingsheng Youxuan, launched in 2018, which caters to consumers by offering fresh produce, meat, seafood, staples, and general merchandise. This platform employs a unique retail model that combines online ordering with offline pick-up, allowing household consumers to meet their daily needs conveniently through a network of community-based convenience stores.
Xpeng Motors
Series C in 2020
Xpeng Motors is a Chinese electric vehicle and technology company that specializes in the design and manufacture of smart cars. The company emphasizes local market needs and prioritizes consumer experience, integrating advanced autonomous driving features and internet-connected technologies into its vehicles. This approach aims to enhance the overall functionality and appeal of their cars, making them more than just traditional vehicles. Additionally, Xpeng Motors has a subsidiary, Xpeng Robotics, which focuses on developing smart robots as part of its broader mobility ecosystem.
Tungee, founded in 2016, specializes in providing intelligent sales solutions for B2B enterprises. By leveraging artificial intelligence and big data, the company has developed a comprehensive sales forecasting platform that encompasses various functions, including lead mining, business opportunity engagement, customer relationship management, and order analysis. Tungee's innovative approach addresses the challenges faced by businesses in identifying, contacting, and managing customers, leading to more efficient acquisition of accurate sales leads and reduced customer acquisition costs. As a leader in the Chinese intelligent sales sector, Tungee has successfully served over 3,000 enterprise clients, including prominent organizations such as Alibaba and China Mobile.
AccuMedical
Series B in 2020
AccuMedical is a full-line product company in the field of neurological intervention, headquartered in Beijing with an R&D center located in California. It develops and produces medical device products for the treatment of aneurysms, preventing, and treating bleeding diseases caused by the rupture of vascular aneurysms.